Estados financieros detallados de Enlivex Therapeutics Ltd. (ENLV): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.81, ENLV cotiza a un P/E de 0.00 y un ROE del 248.08%. La capitalización bursátil es de $14M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | $2.3M | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $25000 | $12000 | $121000 | $297000 | $286000 | $546000 | $777000 | $835000 | $545000 | $332000 |
| Beneficio Bruto | -$25000 | -$12000 | -$121000 | -$297000 | -$286000 | -$546000 | -$777000 | -$835000 | -$545000 | -$332000 |
| I+D | $8.9M | $2.5M | $4.1M | $5.7M | $6.1M | $12.9M | $18.7M | $19.2M | $10.1M | $8.9M |
| Generales y Administrativos | $7.0M | $3.4M | $1.0M | $2.8M | $3.6M | $6.2M | $6.7M | $6.1M | $4.9M | $5.7M |
| Gastos Operativos | $13.9M | $5.8M | $5.2M | $8.6M | $9.8M | $19.3M | $25.8M | $29.4M | $15.0M | $14.7M |
| Beneficio Operativo | -$13.9M | -$5.8M | -$5.3M | -$8.6M | -$9.8M | -$19.3M | -$25.8M | -$29.4M | -$15.5M | -$15.0M |
| EBITDA | -$15.8M | -$5.9M | -$5.2M | -$8.4M | -$9.5M | -$18.7M | -$25.0M | -$28.2M | -$14.5M | -$14.7M |
| Gastos por Intereses | 0 | 0 | $3000 | $7000 | $6000 | $328000 | $5.3M | $14000 | $13000 | $13000 |
| Beneficio Antes de Impuestos | -$15.8M | -$5.9M | -$4.2M | -$9.4M | -$11.8M | -$14.5M | -$31.1M | -$29.1M | -$15.0M | $1.62B |
| Impuestos | $216000 | $28000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $382.6M |
| Beneficio Neto | -$16.0M | -$5.9M | -$4.2M | -$9.4M | -$11.8M | -$14.5M | -$31.1M | -$29.1M | -$15.0M | $1.24B |
| BPA | $-604.35 | $-215.25 | $-159.45 | $-17.55 | $-15.75 | $-8.10 | $-34.65 | $-23.40 | $-10.95 | $405.60 |
| BPA Diluido | $-604.35 | $-208.20 | $-159.45 | $-17.55 | $-15.75 | $-8.10 | $-34.65 | $-23.40 | $-10.95 | $382.20 |
| Acciones en Circulación (Diluidas) | $26510 | $28549 | $30735 | $576632 | $877947 | $1.2M | $1.2M | $1.2M | $1.4M | $3.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $6.9M | $3.5M | $9.7M | $3.9M | $5.7M | $11.2M | $49.9M | $813000 | $3.3M | $2.0M |
| Inversiones a Corto | $3.0M | 0 | $40000 | $8.1M | $30.0M | $72.9M | $299000 | $26.5M | $20.2M | $3.9M |
| Cuentas por Cobrar | $52000 | $28000 | $213000 | $2.4M | $1.2M | $1.1M | $647000 | $229000 | $1.3M | $235000 |
| Inventario | 0 | 0 | 0 | $1.5M | 0 | 0 | $1.2M | 0 | 0 | 0 |
| Activos Corrientes | $10.5M | $3.6M | $10.3M | $16.4M | $38.1M | $86.4M | $52.3M | $33.8M | $26.0M | $1.74B |
| Inmovilizado Material | $71000 | $388 | $685000 | $1.1M | $2.1M | $8.2M | $14.9M | $2.6M | $1.2M | $938000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $410000 | 0 | 0 | 0 | 0 | 0 | $582.5M |
| Activos Totales | $10.6M | $3.6M | $11.0M | $17.6M | $40.4M | $95.1M | $67.6M | $36.8M | $27.7M | $2.33B |
| Cuentas por Pagar | $32000 | $19000 | $173000 | $316000 | $463000 | $878000 | $1.9M | $827000 | $811000 | $3.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $653000 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.9M | $460000 | $1.1M | $6.0M | $4.4M | $4.7M | $6.6M | $6.1M | $3.8M | $9.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.9M | $460000 | $1.3M | $6.3M | $4.9M | $10.1M | $10.8M | $6.7M | $4.1M | $392.1M |
| Reservas | -$39.8M | -$45.8M | -$16.3M | -$25.7M | -$37.5M | -$52.0M | -$83.0M | -$112.1M | -$127.1M | $1.11B |
| Patrimonio Neto | $8.7M | $3.2M | $9.7M | $11.3M | $35.5M | $85.0M | $56.8M | $30.1M | $23.6M | $1.93B |
| Deuda Total | 0 | 0 | 0 | $123000 | $203000 | $6.0M | $4.8M | $1.0M | $534000 | $641000 |
| Deuda Neta | -$9.9M | -$3.5M | -$9.8M | -$11.9M | -$35.5M | -$78.1M | -$45.4M | -$26.3M | -$23.1M | -$5.2M |
| Capital Circulante | $8.6M | $3.2M | $9.1M | $10.4M | $33.7M | $81.7M | $45.7M | $27.7M | $22.2M | $1.73B |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$16.0M | -$5.9M | -$4.2M | -$9.4M | -$11.8M | -$14.5M | -$31.1M | -$29.1M | -$15.0M | $1.24B |
| Amortizaciones | $38000 | $64000 | $121000 | $206000 | $286000 | $546000 | $777000 | $835000 | $545000 | $332000 |
| Compensación en Acciones | $700000 | $408000 | $1.0M | $810000 | $670000 | $2.9M | $2.7M | $2.0M | $2.1M | $1.8M |
| Cambio en Capital Circulante | -$241000 | -$886000 | $83000 | $1.0M | -$306000 | -$1.4M | $804000 | -$1.8M | -$1.2M | $815000 |
| Flujo de Caja Operativo | -$15.5M | -$6.4M | -$3.2M | -$7.0M | -$11.0M | -$17.5M | -$24.0M | -$23.5M | -$13.0M | -$10.4M |
| Inversiones (CapEx) | -$18000 | -$2000 | -$461000 | -$193000 | -$1.0M | -$1.6M | -$8.1M | -$236000 | -$103000 | -$68000 |
| Adquisiciones | 0 | $9000 | 0 | $1.5M | 0 | -$20.0M | -$9.7M | 0 | 0 | $1.4M |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.5M | -$6.4M | -$3.6M | -$7.2M | -$12.0M | -$19.2M | -$32.1M | -$23.8M | -$13.1M | -$10.5M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -100.0% | |||||||||
| Crecimiento Beneficio Neto (anual) | +62.9% | +28.6% | -121.2% | -26.0% | -22.4% | -114.7% | +6.4% | +48.3% | +8329.2% | |
| Crecimiento BPA (anual) | +64.4% | +25.9% | +89.0% | +10.3% | +48.6% | -327.8% | +32.5% | +53.2% | +3804.1% | |
| Cambio en Acciones (anual) | +7.7% | +7.7% | +1776.1% | +52.3% | +35.6% | +3.0% | +1.0% | +10.4% | +136.4% | |
| Crecimiento FCF (anual) | +59.0% | +43.0% | -99.7% | -66.2% | -59.4% | -67.3% | +25.9% | +44.8% | +20.0% | |
| Margen Bruto | -12.6% | |||||||||
| Margen Operativo | -429.7% | |||||||||
| Margen EBITDA | -417.2% | |||||||||
| Margen Neto | -519.3% | |||||||||
| Margen FCF | -528.2% | |||||||||
| Tasa Impositiva Efectiva | -1.4% | -0.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 23.6% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-584.84 | $-222.56 | $-117.85 | $-12.55 | $-13.70 | $-16.10 | $-26.16 | $-19.19 | $-9.59 | $-3.24 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $26510 | $27613 | $30735 | $576632 | $877947 | $1.2M | $1.2M | $1.2M | $1.4M | $3.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 248.08% |
| Rentabilidad sobre capital invertido | -0.49% |
| Rentabilidad sobre activos | 53.10% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 193.24 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -1.03 | -1.24 | -0.58 | -7.17 | -8.03 | -11.57 | -1.71 | -1.73 | -1.60 | 0.03 |
| P/VC | 1.90 | 2.33 | 0.29 | 6.43 | 3.13 | 1.31 | 1.28 | 1.67 | 1.02 | 0.02 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 48.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | -12.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -429.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -519.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: CLGN · CVKD · GDTC · LSTA · MTVA · NCNA · NRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de ENLV: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones